Mitigation and Management Strategies for Ocular Events Associated with Tisotumab Vedotin
Gynecologic oncology（2022）
Key words
Antibody drug conjugate,Cervical cancer,Eye care,Ocular adverse events,Tissue factor,Tisotumab vedotin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined